News & Media

Take a closer look at what we’re doing across Teva worldwide

Our latest news

Late-Breaking Data at the International Headache Society & European Headache Federation Joint Congre...

Late-Breaking Data at the International Headache Society & European Headache Federation Joint Congress 20

Teva and MedinCell Announce FDA Acceptance of New Drug Application for TV-46000/mdc-IRM as a Treatme...

Teva and MedinCell Announce FDA Acceptance of New Drug Application for TV-46000/mdc-IRM as a Treatment fo

Showcasing Teva’s Commitment to Helping Patients Have More Migraine-Free Days, 18 Abstracts will be ...

Showcasing Teva’s Commitment to Helping Patients Have More Migraine-Free Days, 18 Abstracts will be prese

Teva Announces Post Hoc Analysis of Long-Term Data Examining Treatment with AUSTEDO® (deutetrabenazi...

Teva Announces Post Hoc Analysis of Long-Term Data Examining Treatment with AUSTEDO® (deutetrabenazine) T

Teva Generic Medicines Saved the United States $28.8 Billion in 2020, and a Total of $43.1 Billion A...

Teva Generic Medicines Saved the United States $28.8 Billion in 2020, and a Total of $43.1 Billion Across

Teva Reports Second Quarter 2021 Financial Results

Teva Reports Second Quarter 2021 Financial Results

Teva Announces Changes to Executive Management Team

Teva Announces Changes to Executive Management Team

Teva to Host Conference Call to Discuss Second Quarter 2021 Financial Results at 8 a.m. ET on July 2...

Teva to Host Conference Call to Discuss Second Quarter 2021 Financial Results at 8 a.m. ET on July 28, 20

Teva Initiates Voluntary Nationwide Recall of One Lot of Topotecan Injection 4 mg/4 mL (1 mg/mL) Due...

Teva Initiates Voluntary Nationwide Recall of One Lot of Topotecan Injection 4 mg/4 mL (1 mg/mL) Due to Presence of Particulate Matter

Teva and Bioeq Announce Commercial Partnership for Biosimilar

Teva and Bioeq Announce Commercial Partnership for Biosimilar

Feature stories

Discover the world of Teva

Teva: Supporting Pride and the LGBTQ+ Community

Teva: Supporting Pride and the LGBTQ+ Community

Levana Volovsky - Director, Global Regulatory Bridges the Health Equity Gap for Women with MS

Levana Volovsky - Director, Global Regulatory Bridges the Health Equity Gap for Women with MS

Out of the Limelight: Supporting Millions of Non-COVID Patients in Their Journey Back to Healthcare

Out of the Limelight: Supporting Millions of Non-COVID Patients in Their Journey Back to Healthcare

Celebrating Cultural Diversity at Teva

Celebrating Cultural Diversity at Teva

“This ‘invisible pandemic’ is one of the biggest global health challenges”

“This ‘invisible pandemic’ is one of the biggest global health challenges”

Introducing Teva USA’s HBA Rising Stars & Luminary

Introducing Teva USA’s HBA Rising Stars & Luminary

The secret to achieving our new environmental targets? Our people

The secret to achieving our new environmental targets? Our people

Media Resources

Media Inquiries

Contact our corporate communications.

Learn more Media Inquiries

Media Kit

Files and resources for media use only

Download Teva Media Kit Media Kit

Financial Reports

View Teva financial news on our global website.

Learn more Financial Reports

Connect with us

Teva Social Media Guidelines.

Learn more Connect with us